← Back
Data updated: Mar 10, 2026
JOURNEY
Dermatology
JOURNEY is a specialty pharmaceutical company focused on Dermatology. Key products include QBREXZA.
1949
Since
7
Drugs
-
Trials
2
Approved (2yr)
Key Drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 100%
1 drugs
Pipeline Strength Pro
Loading...